Pharmaceutical formulation company Rubicon Research Ltd. launched an initial public offering (IPO) today, October 9, to raise ...
NDTV Profit on MSN
Rubicon Research Raises Rs 619 Crore From Anchor Investors Ahead Of IPO
Rubicon Research on Wednesday announced that it had collected Rs 619 crore from anchor investors, right before its initial-share-sale opening for public subscription. The anchor book saw participation ...
Pharmaceutical company Rubicon Research on Wednesday said it has mobilised Rs 619 crore from anchor investors, ahead of its ...
Rubicon Research raised Rs 619 cr from anchor investors ahead of its IPO. Issue opens Oct 9, closes Oct 13. Details inside.
Pharmaceutical company Rubicon Research on Wednesday said it has mobilised Rs 619 crore from anchor investors, ahead of its initial share-sale opening for public subscription. The anchor book ...
Rubicon Research, a pharmaceutical formulations company based in Mumbai, has announced its IPO with a price band of Rs 461 to Rs 485 per share. The IPO aims to raise Rs 1,377.5 crore, opening for ...
Shares of Rubicon Research are trading at a premium of Rs 80 in the grey market and are expected to list at Rs 583.
IPOs span diverse sectors, including mining, insurance, pharmaceuticals, textiles, and asset management, offering investors a range of opportunities. This article outlines the key details of the ...
Rubicon Research is a pharmaceutical formulation company with a strong focus on R&D and innovation. Its portfolio includes an ...
Explore next week's IPO calendar with major listings like Tata Capital, LG Electronics, and Midwest — see key dates and ...
The Indian primary market is heading for its busiest week yet, with seven IPOs worth more than Rs 30,000 crore opening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results